The long-term evolution of chronic hepatitis B acquired in childhood

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 4, 2009, Pages 433-438

  Manzat Saplacan, Roberta M ^a   Mircea, Petru A ^a   Valean, Simona D ^a   Miu, Nicolae ^a   Burac, Lucia ^a   Valean, Cornel ^a   Nanulescu, Mircea ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Children; Chronic hepatitis B; HBe seroconversion; Interferon therapy; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILDHOOD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; SEROLOGY; TREATMENT OUTCOME; VIROLOGY; VIRUS CARRIER;

ADOLESCENT; ADULT; AGE OF ONSET; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INTERFERONS; LIVER; MALE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 74949112059     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191-211
3. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
4. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174.
5. Yuen MF, Yuan HJ, Wong DK et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 2005; 54: 1610-1614.
6. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterol 1990; 99: 805-810.
7. Sokal EM, Bortolotti F. Update on prevention and treatment of viral hepatitis in children. Curr Opin Pediatr 1999; 11: 384-389.
8. Bortolotti F, Jara P, Barbera C, et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46: 715-718.
9. Jonas MM, Mizerski J, Badia IB, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1706-1713.
10. Iorio R, Giannattasio A, Cirillo F, D' Alessandro L, Vegnente A. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007; 45: 943-949.
11. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539
12. Kane M. Unsafe injections. Bull WHO 1998; 76: 99-100.
13. Frequency of vaccine-related and therapeutic injections - Romania, 1998. Morb Mortal Wkly Rep 1999; 48: 271-274.
14. Miu N, Burac L, Gheban D et al. Evaluation of inteferon and hepatitis B vaccine-therapy in chronic hepatitis B in children. Rom J Gastroenterol 1999; 8: 3-7.
15. Lazar C, Grigorescu-Sido P, et al. Evaluation of viral replication in children with chronic hepatitis B with and without Interferon Treatment. Rom J Gastroenterology 2005; 3: 219-224
16. Orio E, Ichida T, Sakugawa H et al. Geographic distribution of hepatitis B virus genotype in patients with chronic VHB infection in Japan. Hepatology 2001; 34: 590-594.
17. Grandjaques C, Pradat P, Stuyver L et al. Rapid detection of genortypes ana mutations in pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 2000; 33: 430-439.
18. Available at: http://www.icfundeni.ro/imuno-pr.htm
19. Chang MH, Chen PJ, Chen JY, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 1991; 13: 316-320.
20. Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004; 127: 1733-1738.
21. Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006; 43: 556-562.
22. Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998; 29: 184-190.
23. Bortolotti F, Calzia R, Cadrobbi R, et al. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood. J Pediatr 1986; 108: 244-247.
24. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B related sequelae. Arch Intern Med 1990; 150: 1051-1054.
25. Bortolotti F, Wirth S, Crivellaro C, Alberti A, Martine U, de Moliner L. Long term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. J Pediatr Gastroenterol Nutr 1996; 23: 270-274.
26. Marx G, Martin SR, Chicoine JF, et al. Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis 2002; 186: 295-301.
27. Ruiz-Moreno M, Otero M, Millan A, et al. Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology 1999; 29: 572-575.
28. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: With special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995; 22: 1387-1392.